Mayra E Martinez Medina, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4 Calle Hospital, Ciales, PR 00638 Phone: 787-871-0587 Fax: 787-871-4883 |
Carlos A Disdier Rodriguez, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4 Calle Hospital, Ciales, PR 00638 Phone: 787-871-0587 Fax: 787-871-4883 |
Dr. Luis E Tavarez Alarcon, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: Road 149 Km 12.3, Ciales, PR 00638 Phone: 787-871-0601 Fax: 787-871-3960 |
Wilfredo Rivera, Family Medicine Medicare: Medicare Enrolled Practice Location: Carr 149 Km 12.3, Ciales, PR 00638 Phone: 787-871-0601 |
Dr. Carlos Manuel Otero Rivera I, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Carr. 146 Km 27.4, Bo. Cordilleras, Ciales, PR 00638 Phone: 787-871-3919 Fax: 787-871-2376 |
News Archive
Individuals traveling across East Africa on Friday were ordered to begin receiving mandatory yellow fever vaccines in an effort "to contain an outbreak of the disease in Uganda," which has sickened an estimated 190 people, resulting in 48 deaths as of Dec. 30, 2010, the Citizen reports (Ubwani, 1/22).
AstraZeneca today announced its first-ever direct-to-patient program offering patients with a valid prescription for ARIMIDEX or anastrozole the opportunity to have the brand ARIMIDEX delivered directly to their home by Express Scripts, a specialty pharmacy services provider, for $40 per month, including shipping.
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the award of a consulting contract with an existing global research-based biopharmaceutical client to provide clinical data management and trial design services.
Women who took clomiphene citrate (brand name Clomid) or gonadotropins as a part of fertility treatment did not experience an increased risk for breast cancer over 30 years of follow-up, compared with women who were not treated with these medications, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has granted a priority review designation to BENLYSTA (belimumab) as a potential treatment for systemic lupus erythematosus.
› Verified 9 days ago